Abstract
A recent addition to the large arsenal of existing therapies for cancer, oncolytic viruses show great promise as selec- tive anti-tumour agents with high therapeutic effi- cacy. Issues such as tumour selectivity and potential toxicity are being better understood. Several clinical trials are being carried out with oncolytic viruses. This article reviews this prom- ising approach.
Cite
CITATION STYLE
APA
Au, G. G., Barry, R., & Shafren, D. (2005). Oncolytic virotherapy: a brief review. Drugplus International, (June/July), 20–22. Retrieved from http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Oncolytic+virotherapy:+a+brief+review#9
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free